Lycopene Alleviates Lipid Dysregulation, Oxidative Stress, and Hypercholesterolemia in Obese Rats Subjected to a High‐Fat Diet
Food Science & Nutrition · 2025-07 · 13 (7)
DOI: 10.1002/fsn3.70549 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food Science & Nutrition, online erschienen am 07.07.2025. Verfasst von Sana Noreen und 3 weiteren Autor:innen. Beteiligte Einrichtung: University Institute of Diet and Nutritional Sciences, The University of Lahore Lahore Pakistan. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Obesity, driven by high‐calorie diets, is a global health concern closely associated with chronic illnesses such as cardiovascular disease and liver dysfunction. This study investigated the therapeutic potential of lycopene, a potent antioxidant found in tomatoes, in mitigating hyperlipidemia‐induced metabolic disorders in male rats. Obese rats induced by a high‐fat diet (HFD) showed significant increases in body weight (284.12 ± 4.33 g) and serum levels of total cholesterol (TC: 255.21 ± 2.24 mg/dL), triglycerides (TG: 199.23 ± 6.12 mg/dL), LDL‐C (171.27 ± 4.84 mg/dL), and liver enzymes ALT (62.10 ± 3.80 U/L), AST (92.41 ± 1.48 U/L), and ALP (148.18 ± 0.55 U/L), alongside elevated inflammatory cytokines TNF‐α (1279 ± 10.81 pg/mL) and IL‐6 (859 ± 17.3 pg/mL). Treatment with lycopene (30 mg/kg b.w.) over 6 weeks significantly reduced body weight (237.94 ± 3.14 g), TC (180.85 ± 4.99 mg/dL), TG (137.13 ± 5.61 mg/dL), LDL‐C (46.11 ± 2.67 mg/dL), and liver enzyme levels (ALT: 30.34 ± 5.07 U/L, AST: 71.19 ± 2.12 U/L, ALP: 126.30 ± 5.15 U/L). It also improved HDL‐C (48.15 ± 2.35 mg/dL) and antioxidant markers such as SOD (40.62 ± 2.20 U/dL) and CAT (63.66 ± 4.73 U/g), whereas decreasing MDA (29.45 ± 2.33 mM/g), TNF‐α (587 ± 12.9 pg/mL), and IL‐6 (301 ± 16.7 pg/mL) followed by lycopene (25 mg/kg b.w.). Histological analysis showed a marked improvement in liver architecture, with reduced fat accumulation and inflammation. These findings suggest that lycopene supplementation effectively counteracts obesity‐induced dyslipidemia, oxidative stress, and liver inflammation, supporting its potential role as a dietary therapeutic agent for metabolic and hepatic disorders. Future recommendations include conducting long‐term clinical trials in humans to validate these findings, exploring optimal dosages for dietary lycopene supplementation, and investigating its molecular mechanisms of action.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Institute of Diet and Nutritional Sciences, The University of Lahore Lahore Pakistan.
- University Institute of Medical Laboratory Technology, The University of Lahore Lahore Pakistan.
- African Centre of Excellence in Public Health and Toxicological Research (ACE-PUTOR) University of Port-Harcourt Rivers Nigeria.
- Department of Biochemistry, Faculty of Biomedical Sciences Kampala International University Bushenyi Western Uganda Uganda.
ORCID-Profile: Sana Noreen, Patrick Maduabuchi Aja
Zitieren
APA
Noreen, S., Shehzadi, S., Egbuna, C., & Aja, P. M. (2025). Lycopene Alleviates Lipid Dysregulation, Oxidative Stress, and Hypercholesterolemia in Obese Rats Subjected to a High‐Fat Diet. Food Science & Nutrition, 13(7). https://doi.org/10.1002/fsn3.70549
Vancouver
Noreen S, Shehzadi S, Egbuna C, Aja PM. Lycopene Alleviates Lipid Dysregulation, Oxidative Stress, and Hypercholesterolemia in Obese Rats Subjected to a High‐Fat Diet. Food Science & Nutrition. 2025;13(7). doi:10.1002/fsn3.70549
BibTeX
@article{Noreen2025,
author = {Noreen, Sana and Shehzadi, Somia and Egbuna, Chukwuebuka and Aja, Patrick Maduabuchi},
title = {Lycopene Alleviates Lipid Dysregulation, Oxidative Stress, and Hypercholesterolemia in Obese Rats Subjected to a High‐Fat Diet},
journal = {Food Science & Nutrition},
year = {2025},
volume = {13},
number = {7},
doi = {10.1002/fsn3.70549}
}
EUVIMED